Stay updated on Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial

Sign up to get notified when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Enrollment status indicates no new participants are being sought, and new help sections were added alongside a formatting adjustment to the Intervention/Treatment label and a revision bump to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T16:43:22.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A new revision tag 'Revision: v3.5.5' was added, and 'Multiple myeloma', 'related topics' (including MedlinePlus Genetics), and the earlier revision tag 'Revision: v3.5.4' were removed, indicating a cleanup of page metadata.
    Difference
    0.2%
    Check dated 2026-06-05T12:57:09.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Added a related topics block for Multiple myeloma under MedlinePlus Genetics on the study page, providing access to additional health information about the condition.
    Difference
    0.2%
    Check dated 2026-05-29T09:11:24.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The related topics header and two topic entries were removed from the page, reducing the displayed connections to the study.
    Difference
    0.2%
    Check dated 2026-05-22T08:43:04.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Added related-topic keywords (Multiple myeloma and MedlinePlus Genetics) and updated the site revision from v3.5.3 to v3.5.4.
    Difference
    0.2%
    Check dated 2026-05-15T02:17:38.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The page's explicit disease label and related resources are removed, reducing the visible context and cross-links to genetics information on this study record.
    Difference
    0.2%
    Check dated 2026-05-07T23:22:44.000Z thumbnail image

Stay in the know with updates to Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.